NFKB1 and neoplasm: CBD suppresses the activation of the EGF/EGFR signaling pathway and its downstream targets Akt, ERK and NF-κB in multiple tumor cells, which demonstrates that there might be a potential role for CBD to interfere in the cross-talk between inflammation, cell survival and tumor proliferation [85,89,119].